604 related articles for article (PubMed ID: 16740715)
21. Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells.
Folini M; Brambilla C; Villa R; Gandellini P; Vignati S; Paduano F; Daidone MG; Zaffaroni N
Eur J Cancer; 2005 Mar; 41(4):624-34. PubMed ID: 15737568
[TBL] [Abstract][Full Text] [Related]
22. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor.
Wu P; Meng L; Wang H; Zhou J; Xu G; Wang S; Xi L; Chen G; Wang B; Zhu T; Lu Y; Ma D
Biochem Biophys Res Commun; 2005 Sep; 335(1):36-44. PubMed ID: 16051188
[TBL] [Abstract][Full Text] [Related]
23. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner.
Zhao P; Wang C; Fu Z; You Y; Cheng Y; Lu X; Lu A; Liu N; Pu P; Kang C; Salford LG; Fan X
Int J Oncol; 2007 Aug; 31(2):361-8. PubMed ID: 17611693
[TBL] [Abstract][Full Text] [Related]
24. [Inhibitory effect of RNAi targeting human telomerase reverse transcriptase against human hepatocellular carcinoma cells].
Li H; Wang XL; Yang Y; Zhang J; Wang GS; Jiang N; Chen GH
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1323-6. PubMed ID: 18753050
[TBL] [Abstract][Full Text] [Related]
25. Telomere length homeostasis requires that telomerase levels are limiting.
Cristofari G; Lingner J
EMBO J; 2006 Feb; 25(3):565-74. PubMed ID: 16424902
[TBL] [Abstract][Full Text] [Related]
26. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
[TBL] [Abstract][Full Text] [Related]
27. [Inhibition of anti-sense human telomerase reverse transcriptase (hTERT) retroviral vector on lung cancer cells].
Tian FJ; Wang ZY; Ma JY; Zhao YX; Lu W
Ai Zheng; 2004 May; 23(5):545-9. PubMed ID: 15142451
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of telomerase activity in cancer cells using short hairpin RNA expression vectors.
Chen SM; Tao ZZ; Hua QQ; Xiao BK; Xu Y; Wang Y; Deng YQ
Cancer Invest; 2007 Dec; 25(8):691-8. PubMed ID: 18058464
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of human telomerase reverse transcriptase through specific activation of RNAi pathway quickly results in cancer cell growth impairment.
Gandellini P; Folini M; Bandiera R; De Cesare M; Binda M; Veronese S; Daidone MG; Zunino F; Zaffaroni N
Biochem Pharmacol; 2007 Jun; 73(11):1703-14. PubMed ID: 17321502
[TBL] [Abstract][Full Text] [Related]
30. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
31. [The anti-cancer effect of siRNA targeting human telomerase reverse transcriptase in SMMC-7721 cells].
Zheng SJ; Xia Y; Ren H; Zhong S; Yang Y; Tao P; Wang SQ
Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):530-3. PubMed ID: 15387903
[TBL] [Abstract][Full Text] [Related]
32. Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.
Kraemer K; Fuessel S; Schmidt U; Kotzsch M; Schwenzer B; Wirth MP; Meye A
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3794-800. PubMed ID: 14506173
[TBL] [Abstract][Full Text] [Related]
33. A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation.
Kim MM; Rivera MA; Botchkina IL; Shalaby R; Thor AD; Blackburn EH
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7982-7. PubMed ID: 11438744
[TBL] [Abstract][Full Text] [Related]
34. Telomerase activity does not always imply telomere maintenance.
Ouellette MM; Aisner DL; Savre-Train I; Wright WE; Shay JW
Biochem Biophys Res Commun; 1999 Jan; 254(3):795-803. PubMed ID: 9920820
[TBL] [Abstract][Full Text] [Related]
35. New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin.
Chan SW; Blackburn EH
Oncogene; 2002 Jan; 21(4):553-63. PubMed ID: 11850780
[TBL] [Abstract][Full Text] [Related]
36. Apoptosis and reduced cell proliferation of HL-60 cell line caused by human telomerase reverse transcriptase inhibition by siRNA.
Miri-Moghaddam E; Deezagi A; Soheili ZS; Shariati P
Acta Haematol; 2010; 124(2):72-8. PubMed ID: 20628241
[TBL] [Abstract][Full Text] [Related]
37. Immortal ALT+ human cells do not require telomerase reverse transcriptase for malignant transformation.
Sun B; Chen M; Hawks CL; Hornsby PJ
Cancer Res; 2005 Aug; 65(15):6512-5. PubMed ID: 16061628
[TBL] [Abstract][Full Text] [Related]
38. siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression.
Mei YP; Zhu XF; Zhou JM; Huang H; Deng R; Zeng YX
Cancer Lett; 2006 Feb; 232(2):189-98. PubMed ID: 16458115
[TBL] [Abstract][Full Text] [Related]
39. Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line.
Song JS; Kim HP
Oncol Rep; 2004 Aug; 12(2):443-7. PubMed ID: 15254714
[TBL] [Abstract][Full Text] [Related]
40. Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells.
Duan J; Chen Z; Liu P; Zhang Z; Tong T
Int J Oncol; 2004 Jun; 24(6):1597-605. PubMed ID: 15138605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]